Characteristic | Data |
---|---|
NAT | |
CTx (including Gleevec) | 11 (42%) |
CRTx | 10 (38%) |
RTx | 2 (8%) |
No neoadjuvant | 3 (12%) |
Surgery | 24 (92%) |
Adjuvant therapy | |
CTx | 11 (42%) |
CRTx | 3 (12%) |
RTx | 2 (8%) |
No adjuvant therapy | 6 (23%) |
Incomplete records | 4 (15%) |
Recurrent therapy | |
CTx | 3 (12%) |
Surgery | 3 (12%) |
Surgery + CTx | 2 (8%) |
Surgery + RTx | 1 (4%) |
Surgery + CRTx | 1 (4%) |
Recurrence with incomplete records of retreatment | 7 (27%) |
Incomplete records of recurrence/retreatment | 3 (12%) |
No recurrence | 6 (23%) |
Pathologic | |
Responder | 3 (13%) |
Nonresponder | 21 (87%) |
CTx = chemotherapy; CRTx = chemoradiation therapy; RTx = radiation therapy.
Data are number followed by percentage in parentheses, except for age.